Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intratympanic Application of Betahistine for Menière Disease-An Animal Study on Safety and Diffusion to the Inner Ear.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Depigmented Facial and Neck Patches Following Melanotan Use in a Patient With Atopic Dermatitis and Alopecia Areata.

Clinical and experimental dermatology·2026
Same author

Development of Poliosis in Patients Treated With Immunotherapy for Metastatic Cutaneous and Non-Cutaneous Melanoma.

Pigment cell & melanoma research·2026
Same author

Treatment of Acne Keloidalis Nuchae in a Southern California Population.

Cutis·2026
Same author

Acquisition of bedaquiline and clofazimine resistance in association with a novel loss-of-function mutation in the <i>pepQ</i> gene during treatment of multidrug-resistant tuberculosis.

ASM case reports·2026
Same author

The road to 100: single center experience with the first 100 consecutive robotic kidney transplants.

Journal of robotic surgery·2026

Related Experiment Video

Updated: May 4, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K

Program Director Perspectives on DEI Initiatives in the Dermatology Residency Selection Process.

Ogechi Obed1, Ivan Rodriguez1, Karen Lam1

  • 1Ogechi Obed, Ivan Rodriguez, and Dr. Worswick are from the Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles. Karen Lam is from the Department of Dermatology, David Geffen School of Medicine, University of California Los Angeles. Dr. Van Beek is from the Department of Dermatology, University of Iowa Health Care, Iowa City. Dr. Rosenblatt is from the Section of Dermatology, Departments of Medicine and Pediatrics, University of Chicago Pritzker School of Medicine, Illinois. Dr. Saavedra is from the Department of Dermatology, University of Virginia School of Medicine, Charlottesville.

Cutis
|January 29, 2025
PubMed
Summary

Dermatology program directors support diversity, equity, and inclusion (DEI) initiatives in resident selection. However, legal challenges and knowledge gaps hinder progress, emphasizing the need for continued DEI efforts in dermatology.

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.6K

Related Experiment Videos

Last Updated: May 4, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.6K

Area of Science:

  • Medical Education
  • Dermatology Workforce Diversity

Background:

  • The American Academy of Dermatology (AAD) has historically supported diversity, equity, and inclusion (DEI).
  • Recent US Supreme Court rulings on affirmative action have raised questions about DEI program viability.
  • Understanding program director (PD) perspectives is crucial for navigating these changes.

Purpose of the Study:

  • To assess dermatology PDs' perceptions of DEI programming.
  • To investigate the integration of DEI into dermatology residency selection processes.
  • To identify challenges and facilitators for DEI in dermatology graduate medical education.

Main Methods:

  • A cross-sectional survey was distributed to PDs of US dermatology residency programs.
  • Data were collected between April 2024 and July 2024.
  • Thirty PDs participated in the survey.

Main Results:

  • A majority of PDs expressed strong support for advancing DEI in dermatology.
  • PDs reported persistent challenges, including legal restrictions and knowledge deficits regarding DEI implementation.
  • Support for DEI exists despite perceived barriers.

Conclusions:

  • Sustained commitment and strategic planning are necessary to foster a diverse and inclusive dermatology workforce.
  • Addressing legal uncertainties and enhancing PD knowledge are key to overcoming current challenges.
  • Aligning the dermatology workforce with national demographic diversity remains an important goal.